For patients currently using licensed injectable GLP-1 receptor agonists in the UK: Once-daily formulations include liraglutide (Victoza) [2] Once-weekly formulations include semaglutide (Ozempic), dulaglutide (Trulicity), and exenatide extended-release (Bydureon) [1] [2] If you are participating in a clinical trial involving a GLP-1 patch, you must strictly follow the specific instructions provided by the research team regarding application duration, replacement schedule, and all other aspects of use
Do not exceed the recommended frequency without medical supervision
doi: 10.1038/s41467-019-10038-x 68 ZamponiGWCurrieKP
Extra-large pad design covers cheeks, forehead, and neck effortlessly, while remaining gentle enough for sensitive skin with dermatologist-tested safety
Adds a second trigger Ipamorelin mimics the 'hunger hormone' to spark its own separate pulse
For this reason, analytical documentation and laboratory testing records are carefully maintained to support research validation, compliance requirements, and scientific accountability
